SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-042630
Filing Date
2019-11-12
Accepted
2019-11-12 08:40:55
Documents
14
Period of Report
2019-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrtx-8k_20191112.htm   iXBRL 8-K 35269
2 EX-99.1 hrtx-ex991_17.htm EX-99.1 160552
3 GRAPHIC gdidakotli4k000001.jpg GRAPHIC 7436
  Complete submission text file 0001564590-19-042630.txt   347442

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20191112.xsd EX-101.SCH 5964
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20191112_lab.xml EX-101.LAB 19478
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20191112_pre.xml EX-101.PRE 11627
9 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-8k_20191112_htm.xml XML 3568
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 191206395
SIC: 2834 Pharmaceutical Preparations